|
New Delhi, Jan 09: Almost a year into the COVID-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several countries or are under limited emergency use.
Representational Image
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
COVAXIN
Developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology, the indigenous vaccine was granted emergency use authorisation in ‘clinical trial mode’ by the Indian government this week.
It is an “inactivated” vaccine developed by chemically treating novel coronavirus samples to make them incapable of reproduction. This…
